Case File
efta-efta01450509DOJ Data Set 10CorrespondenceEFTA Document EFTA01450509
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01450509
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
12/11/2013 11:44 AM
Subject:
Re: DXJ [C]
yes
on wed, Dec 11, 2013 at 12:43 PM, vahe stepanian
wrote:
classification: confidential
Jeffrey,
As a follow up to your conversation with Paul, please confirm you would like
to purchase 60,000 DX7 @ market.
DXl is currently trading —$49.36, therefore the position = —$3mm exposure.
I'111 be back to you shortly on AAL.
Thank you,
vahe
(Embedded image moved to file: pic15353.gif)
Vahe stepanian
Associate I Wealth Investment Coverage
Deutsche Bank Securities Inc.
Deutsche Asset & wealth Management
345 Park Avenue - 26th Floor
New York, NY 10154-0004
Tel. +1 (212) 454-1539
Fax +1 (646) 257-3131
Mobile +1 347 854-4676
Email
(Embedded image moved to file: pic18169.gif)
This communication may contain confidential and/or privileged information.
If you are not the intended recipient (or have received this communication
in error) please notify the sender immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the
material in this communication is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
freteie******************************************************Ile
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
CONFIDENTIAL — PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0 106173
CONFIDENTIAL
SDNY_GM_00252357
EFTA01450509
Technical Artifacts (5)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Fax
Fax +1 (646) 257-3131Phone
+1 (212) 454-1539Phone
+1 (646) 257-3131Phone
+1 347 854-4676Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.